Publisher: Elsevier.
Beneficial Effects on Sleep of Vagus Nerve Stimulation in Children with

INTRODUCTION
Repetitive vagus nerve stimulation (VNS) is a neurophysiologic method for treatment of refractory epilepsy. VNS has proved to be efficacious and well tolerated in adults. 1, 2 Paediatric studies have shown even better and more rapid response. More than 50% seizure reduction was reported in 27-57% of the children. [3] [4] [5] [6] These uncontrolled open studies also
showed an improvement in wellbeing and quality of life (QOL). In adults without epilepsy, VNS has caused a significant reduction in depressive symptoms. 7 Armitage et al. 8 presented an improvement in both depression and sleep architecture. Galli et al. 9 recently confirmed the positive effect of VNS on QOL in adults with epilepsy and learning disability and presented improvement in daytime vigilance. Mechanisms explaining the action of VNS on the Central nervous system (CNS) are still unknown. Over the last years VNS has been shown in several animal studies, and recently in some human studies to suppress both ictal and interictal epileptiform EEG activity. [10] [11] [12] [13] [14] In an earlier report we present the findings that VNS reduces interictal epileptiform discharges in Rapid eye movement (REM) and slow wave sleep (SWS), and the number of electrographic seizures. 15 The effects of VNS on sleep in patients with medically refractory epilepsy have only been elucidated in a few studies and so far not in children. Vaughn et al. 16 report, in a short abstract, a decrease in REM-sleep at high intensity and high frequency VNS and an increase in REM-sleep at low intensity and low frequency VNS. Malow et al. 17 described that VNS at low stimulus intensity counteracts daytime sleepiness, even in subjects without reduction in seizure frequency. Daytime REM-sleep was enhanced with VNS. Rizzo et al. 18 reported improved daytime alertness and reduced REM-sleep.
Microarchitectual studies of all-night delta power to reflect homeostatic regulation and restitution of sleep after sleep-deprivation is extensively studied and summarized by Finelli,
Borbély and Achermann. 19 Huber et al. 20 described that sleep homeostasis can be induced on a local level and benefit or be triggered by a learning task or performance. Thus SWS homeostasis may reflect synaptic changes underlying a cellular need for sleep. Increased delta power, following VNS, associated with increased wakefulness and anti-depressive effects were presented by Rizzo et al. 18 and Armitage et al. 8 In this study we report changes in sleep structure and delta power following VNS in 15 children with therapy-resistant epilepsy, and how these changes correlate with epileptiform activity and clinical effects on seizure reduction and QOL.
METHODS
Subjects
The study group comprises 15 children (10 boys and five girls) aged 4 -17 years (median 11 years) with the diagnosis of therapy-resistant epilepsy with developmental impairment, and absence of non-epileptic seizures or specific sleep disorders. Epilepsy surgery had been performed in patient 2, 4, 11 and 12 and found not applicable in the others. Additional clinical features of the patients are given in Table 1 . All patients had been on stable anti-epileptic drug medication for at least three months prior to the VNS initiation and during the nine months of follow up. Written informed consent was obtained. The study was accepted by the Ethics
Committee of the Faculty of Medicine of the Lund University.
VNS
The VNS device (NCP System; Cyberonics, Houston, TX, USA) was implanted according to the established guidelines. 21 At the end of the surgical procedure, the device is programmed with the following parameters: output current 0.25mA; signal frequency 30Hz; pulse-width 500µsec; stimulation on-time 30sec; stimulation off-time 5min. During the initial 4 weeks, the output current is increased in steps of 0.25mA to 1-1.5mA and is then kept stable during the nine months of follow-up.
Polysomnographic recordings
Continuous EEG recordings for polysomnography (PSG) were performed during 24 hours initially, and after three and nine months of VNS-treatment. The recordings were ambulatory with the children in their natural surroundings. Twenty-four hour recordings were performed to obtain enough artefact-free data and over-night sleep recording for quantification of sleep. 
Monitoring
Initially and after three and nine months of VNS-treatment, epileptiform activity was counted in comparable assessment periods according to time of day and activity stage. Two hours of artefact-free EEG was selected from wake and one hour of artefact-free EEG was selected from three different sleep stages defined as rapid eye movement (REM), sleep stadium two, with theta activity, sleep spindles and <50% slow wave sleep, and sleep stadium 3+4 with >50% slow wave sleep (Table 2A) .
During three months before VNS initiation, a diary of seizure frequency and severity was collected together with clinical data. The severity of the seizures was scored with the National Hospital Seizure Severity Scale (NHS3), a further development of the Chalfont Seizure Severity Scale described by O'Donoghue et al. 22 QOL was assessed by a visual analogue scale and parents' perception of the children's general behaviour problems were quantified by using the total score of the Child Behaviour Checklist (CBCL). Follow-up assessments were performed at three and nine months after VNS initiation (Table 2B) . 23 
Delta power
The digitalized data were converted to Nervus Taugagreining 
Sleep scoring
The medians and ranges of PSG sleep macro-architecture variables are shown in Table 3 .
Significant differences, with an increase in SWS in both duration (p=0.03) (Fig. 1) and percentage (p=0.04) and a decrease in stage 1 sleep in both duration (p=0.03) and percentage (p=0.03) were seen at 9 months of VNS. A significant decrease was seen in sleep latency after 9 months of VNS (p=0.04) and a non-significant decrease of daytime sleep was seen at 3 and 9 months (p=0.07, 0.16).
Delta power
There was a tendency towards increase in total delta power and delta power in the first two sleep cycles, significantly so in sleep cycle 2 after 9 months of VNS (p=0.05) ( Table 3) .
Movement Time
The total number MTs (p=0.08, 0.01) and the number per hour TNS (p=0.09, 0.009) ( Table3) were increased, significantly so at 9 months. When considering MTs in the different sleep stages separately, there was a tendency towards increase in all stages and significantly so in sleep stage 2 (p=0.02) and SWS (p=0.03) at 9 months. The difference in total number of MTs between the VNS stimulation periods and post VNS stimulation periods was highly significant at both 3 and 9 months (p<0.001). The median number of MTs was significantly larger during the VNS stimulation period compared with the pre-and post-stimulation periods respectively (p=0.002, 0.007 at 3 months and p=0.005, 0.005 at 9 months). The median and range of the different children's VNS stimulus related MTs are presented in Fig.   3 . A case with exceptional high stimulus related MTs is described in Table 3) and a tendency towards reduction in daytime sleep, probably contributing to improved wellbeing. [27] [28] [29] In our study the improvement in QOL was significant for the whole group (p=0.03). There was concordance in direction of changes between enhanced SWS and QOL in 9 of 15 children. We could not prove any direct quantitative correlation between improved QOL and increased SWS. This may be due to the small number of patients and the fact that increased SWS is only one of several contributing factors to improved QOL together with decreased epileptiform activity, seizure frequency and severity. Parker et al. 5 and George et al. 30 reported that the effects of VNS are positively correlated to the length of the treatment period. In this view 9 months may still be a too short observation time to find effects on sleep architecture in addition to effects on epileptiform activity. Rizzo et al. 18 and Armitage et al. 8 reported increased delta power associated with increased wakefulness and anti-depressive effects, following VNS. Slow wave sleep as a neurophysiologic marker of sleep homeostasis 27,28 is enhanced by VNS. In this study, we only see a tendency of increased delta power especially in sleep cycle two (p=0.05). This might be due to the small number of patients with severe epileptic encephalopathy and enhanced background delta during wake, even though patients 6 and 15 with CSWS were excluded, and artefacts were carefully provided for. One should also note that SWS is classified as sleep stadium 3 and 4 according to Rechtschaffen and Kales criteria, 24 and includes both delta and theta frequencies. Delta power include only delta (0,5 -4 Hz). The enhancement of deep non-REM sleep seen after VNS might be produced by other mechanisms than that produced by simple sleep deprivation.
Such mechanisms may be related to a GABA mediated thalamic influence further discussed below.
We used the MT as a sign of arousal. We show that MTs increase in total number, number/hour TNS and particularly in sleep stage 2 and SWS during long time VNS treatment.
The finding of a highly significant increase of MTs in immediate association to the VNS stimulation, support the theory that MTs seems to be directly related to the VNS-stimulation.
These findings differ from the gradual increase in SWS indicating different mechanisms of effect of VNS, see Table 3 . MT and arousals following VNS may be one of several antiepileptic mechanisms of VNS. It is well known that arousals during sleep can be proepileptic. 31 It is also well known that deliberate alerting can produce a reduction in epileptic seizures. 32,33 Nagai et al. 34 describes the therapeutic potential of biofeedback in reducing seizure frequency in patients with therapy-resistant epilepsy. Both epilepsy and increased arousals can lead to sleep deprivation and fragmentation possibly associated with degraded QOL. Despite these possible adverse effects we see an improvement in QOL in the whole group at nine months and a decrease in epileptiform activity, seizure frequency and severity ( 39 showed that LC lesion suppresses the seizure-attenuating effects of VNS.
In conclusion the aim of this study was to evaluate changes in sleep structure following VNS.
We see that VNS counteracts known adverse effects of epilepsy on sleep and increases SWS.
This possibly contributes to improved wellbeing. We also see an increase in MTs. This arousal effect seems in most cases to be of minor consequence for QOL and may even be one of several antiepileptic mechanisms in VNS. 
